Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 USD | -1.14% | +4.20% | +27.44% |
03-14 | Vaxart, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-14 | Transcript : Vaxart, Inc., 2023 Earnings Call, Mar 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.44% | 129M | |
+2.93% | 108B | |
-3.76% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- VXRT Stock
- News Vaxart, Inc.
- Vaxart Says Topline Data From Phase 2 Challenge Study of Monovalent Norovirus Vaccine Meets 5 of 6 Endpoints